Teva Pharmaceutical Industries
TEVA
A$26.49
Share price
1.38%
Change (1 day)
6.91%
Change (1 year)
Categories
Earnings for Teva Pharmaceutical Industries (TEVA)
Earnings in 2025 (TTM): A$0.73 Billion
According to Teva Pharmaceutical Industries's latest financial reports the company's current earnings are A$16.61 Billion. In 2024 the company made an earning of -A$0.44 Billion a decrease over its 2023 earnings that were of A$0.57 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Teva Pharmaceutical Industries from 1986 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | A$0.73 B | -269.48% |
| 2024 | -A$0.44 Billion | -176.01% |
| 2023 | A$0.57 B | -117.37% |
| 2022 | -A$3.29 Billion | -237.81% |
| 2021 | A$2.38 B | -145.01% |
| 2020 | -A$5.31 Billion | 796.88% |
| 2019 | -A$0.6 Billion | -77.09% |
| 2018 | -A$2.59 Billion | -90.43% |
| 2017 | -A$26.96 Billion | -1377.66% |
| 2016 | A$2.10 B | -47.75% |
| 2015 | A$4.03 B | -33.42% |
| 2014 | A$6.06 B | 151.79% |
| 2013 | A$2.40 B | -28.06% |
| 2012 | A$3.34 B | -35.7% |
| 2011 | A$5.20 B | -12.66% |
| 2010 | A$5.96 B | 59.1% |
| 2009 | A$3.74 B | 112.49% |
| 2008 | A$1.76 B | -52.19% |
| 2007 | A$3.68 B | 12.57% |
| 2006 | A$3.27 B | 62.05% |
| 2005 | A$2.02 B | 11.79% |
| 2004 | A$1.80 B | 32.73% |
| 2003 | A$1.36 B | 68.85% |
| 2002 | A$0.80 B | 39.17% |
| 2001 | A$0.57 B | 0.35% |
| 2000 | A$0.57 B | 88.6% |
| 1999 | A$0.30 B | 37.4% |
| 1998 | A$0.22 B | -16.69% |
| 1997 | A$0.26 B | 34.42% |
| 1996 | A$0.19 B | 12.24% |
| 1995 | A$0.17 B | 7.97% |
| 1994 | A$0.16 B | 21.39% |
| 1993 | A$0.13 B | 46.26% |
| 1992 | A$92.54 M | 16.7% |
| 1991 | A$79.3 M | 4.89% |
| 1990 | A$75.6 M | -0.2% |
| 1989 | A$75.76 M | 100.82% |
| 1988 | A$37.72 M | |
| 1986 | A$74.22 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novartis NVS | A$22.97 B | 3,185.90% | 🇨🇭 Switzerland |
 Sanofi SNY | A$13.52 B | 1,834.02% | 🇫🇷 France |
 GlaxoSmithKline GSK | A$8.33 B | 1,091.87% | 🇬🇧 UK |
 Pfizer PFE | A$15.92 B | 2,177.75% | 🇺🇸 USA |
 Merck MRK | A$33.02 B | 4,624.67% | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | A$1.42 B | 103.30% | 🇮🇳 India |
 AstraZeneca AZN | A$16.89 B | 2,316.52% | 🇬🇧 UK |